Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Central role of the P2Y12 receptor in platelet activation
Robert T. Dorsam, Satya P. Kunapuli
Robert T. Dorsam, Satya P. Kunapuli
View: Text | PDF
Spotlight

Central role of the P2Y12 receptor in platelet activation

  • Text
  • PDF
Abstract

Platelet activation occurs in response to vessel injury and is important for the arrest of bleeding. Platelet activation during disease states leads to vascular occlusion and ischemic damage. The P2Y12 receptor, activated by ADP, plays a central role in platelet activation and is the target of P2Y12 receptor antagonists that have proven therapeutic value.

Authors

Robert T. Dorsam, Satya P. Kunapuli

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Intracellular signaling events downstream of the P2Y1 and P2Y12 receptor...
Intracellular signaling events downstream of the P2Y1 and P2Y12 receptors. ADP binds to the P2Y12 receptor and causes a number of intracellular signaling events downstream of the Gi pathway that contribute to fibrinogen receptor activation and platelet aggregation. The P2Y12 receptor–mediated inhibition of adenylyl cyclase is not directly responsible for fibrinogen receptor activation. Potassium channels and PI3K are also activated by the P2Y12 receptor. Both Rap1b and Akt are signaling mediators that contribute to platelet aggregation and are activated in a PI3K-dependent manner. Other mediators of P2Y12 signaling remain to be elucidated.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts